Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00690560 |
Recruitment Status
:
Completed
First Posted
: June 4, 2008
Last Update Posted
: February 10, 2015
|
Sponsor:
Centre Antoine Lacassagne
Information provided by (Responsible Party):
Centre Antoine Lacassagne
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | March 2010 |
Actual Study Completion Date : | October 2010 |